GSTM1, glutathione S-transferase mu 1, 2944

N. diseases: 627; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0149725
Disease: Lower respiratory tract infection
Lower respiratory tract infection
0.010 GeneticVariation group BEFREE In addition, PM<sub>2.5</sub> exposure during the third trimester increased the risk of LRTIs at 1 year of age in cases with the GSTM1 null genotype (aRR, 1.26; 95% CI, 1.01-1.57; P for interaction .20). 31746563 2020
CUI: C0008350
Disease: Cholelithiasis
Cholelithiasis
0.010 GeneticVariation disease BEFREE This is the first study to investigate the role of genetic variants of GSTM1 and GSTT1 in GBC in Kashmir valley and cholelithiasis in the world. 31755784 2019
CUI: C0014038
Disease: Encephalitis
Encephalitis
0.010 Biomarker disease BEFREE In vivo, astrocyte-specific knockdown of GSTM1 in the prefrontal cortex attenuated microglia activation in brain inflammation induced by systemic injection of lipopolysaccharides (LPS). 30783009 2019
Sensorineural Hearing Loss (disorder)
0.010 GeneticVariation disease BEFREE Several studies have reported that antioxidant gene glutathione s-transferase M1 and T1 (GST M1 and T1) polymorphisms have a close relationship with the susceptibility to acquired SNHL, but other articles have reported opposite results. 30696891 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.010 GeneticVariation disease BEFREE GSTM1 and GSTT1 null genotypes are not a risk features for nephrolithiasis. 31445152 2019
CUI: C0079773
Disease: Lymphoma, T-Cell, Cutaneous
Lymphoma, T-Cell, Cutaneous
0.010 Biomarker disease BEFREE Resistant CTCL exhibited high levels of histone acetylation, which correlated with increased expression of 338 genes (FDR < 0·05), including some novel to CTCL: BIRC5 (anti-apoptotic); RRM2 (cell cycle); TXNDC5, GSTM1 (redox); and CXCR4, LAIR2 (cell adhesion/migration). 31358475 2019
CUI: C0156344
Disease: Endometriosis of ovary
Endometriosis of ovary
0.010 GeneticVariation disease BEFREE Methylation levels of the GSTM1 promoter region in the ectopic and eutopic endometrial tissues of patients with ovarian endometriosis and the endometrial tissues of women without endometriosis were analysed by pyrosequencing. 30989213 2019
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis
0.010 GeneticVariation disease BEFREE GSTM1 and GSTT1 null genotypes are not a risk features for nephrolithiasis. 31445152 2019
Left ventricular diastolic dysfunction
0.010 GeneticVariation disease BEFREE Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients. 30095041 2019
CUI: C1301700
Disease: Cardiovascular morbidity
Cardiovascular morbidity
0.010 GeneticVariation phenotype BEFREE Subjects without cardiovascular morbidity with homozygous GSTM1 gene deletion appeared to be more susceptible to the effects of TPM<sub>10</sub>. 30716571 2019
High Grade Intraepithelial Neoplasia
0.010 GeneticVariation disease BEFREE The GSTT1 null genotype was also related to high-grade intraepithelial neoplasia (HSIL) and cervical cancer risk (OR = 1.30 and OR = 1.78, respectively, P < .05).The GSTM1 null variant caused cervical lesions, especially among HPV infection cases and among the Chinese and Indian populations. 31593112 2019
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.010 GeneticVariation disease BEFREE The combination of GSTM1 active and GSTT1 active genotype decreased the risk of ASD (OR = 0.126, 95%CI: 0.029-0.547, p = 0.006), as well as combination of GSTT1 active and GSTP1 llelle (OR = 0.170, 95%CI: 0.029-0.992, p = 0.049). 30824761 2019
CUI: C1847540
Disease: Azoospermia, Nonobstructive
Azoospermia, Nonobstructive
0.010 GeneticVariation disease BEFREE However, the GSTM1 null genotype was associated with OAT, but not NOA in Chinese populations. 30732132 2019
CUI: C3164407
Disease: Oligoasthenozoospermia
Oligoasthenozoospermia
0.010 GeneticVariation disease BEFREE However, the GSTM1 null genotype was associated with OAT, but not NOA in Chinese populations. 30732132 2019
Idiopathic pulmonary arterial hypertension
0.010 Biomarker disease BEFREE Upregulated caveolin-1, filamin A, and cathepsin D combined with increased macrophagocytes and downregulated GSTM1 may be potential biomarkers and targets in the irreversibility CHD-PAH, and which may be useful in evaluating the operability and understanding the irreversibility of CHD-PAH. 29480151 2019
CUI: C3662490
Disease: Acquired sensorineural hearing loss
Acquired sensorineural hearing loss
0.010 GeneticVariation disease BEFREE Association of Glutathione s-transferase M1 and T1 gene polymorphisms with the susceptibility to acquired sensorineural hearing loss: a systematic review and meta-analysis. 30696891 2019
CUI: C4554344
Disease: IgE-mediated food allergy
IgE-mediated food allergy
0.010 GeneticVariation disease BEFREE Development of FA was associated with longer periods of breastfeeding (adjusted OR = 1.792, P = .03), and this dietary pattern was more significantly related to the development of FA in infants with the homozygous TT genotype of CD14 (rs2569190) and more than 1 copy of GSTM1 and GSTT1. 30930272 2019
CUI: C0002893
Disease: Refractory anemias
Refractory anemias
0.010 Biomarker disease BEFREE An mRNA expression analysis revealed that CYP1A2 and CYP2E1 levels were decreased while those of NQO1, GPx, and GSTm1 increased after S. fruticosa and RA treatments. 28718679 2018
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 GeneticVariation group BEFREE Frequencies of GSTM1 and GSTT1 deletions were shown to be 21.9% and 19.8%, respectively, in the HIV patients, and patients with homozygous deletion of both GSTM1 and GSTT1 were more likely to have their CD4+ count rising above 350 cells/mm3 (OR = 6.44, 95% CI = 0.81-51.49, p = 0.039) suggesting that patients with homozygous deletion of GSTM1 and GSTT1 genes have slower disease progression. 29795558 2018
CUI: C0025281
Disease: Meniere Disease
Meniere Disease
0.010 Biomarker disease BEFREE Remarkably, GSTM1 might be a possible candidate gene for the diagnostic biomarker of MD and provides the basis for further biological and functional investigations. 29164594 2018
CUI: C0406317
Disease: Chronic small plaque psoriasis
Chronic small plaque psoriasis
0.010 GeneticVariation disease BEFREE The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene polymorphism in patients with chronic plaque psoriasis as a factor in the susceptibility and development of psoriasis. 29067933 2018
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.010 GeneticVariation disease BEFREE Our novel findings indicate GSTM1 could be a risk locus in MetS development and shed light novel scenarios on the role of glucose fluctuations in neurological impairments. 29452132 2018
CUI: C1304470
Disease: Generalized vitiligo
Generalized vitiligo
0.010 GeneticVariation disease BEFREE This study showed a significant trend towards an association with the combination of the GSTM1/GSTT1 double null polymorphism and generalized vitiligo. 29641697 2018
CUI: C3826758
Disease: AIDS (Disease)
AIDS (Disease)
0.010 GeneticVariation disease BEFREE This study sought to investigate the association between homozygous deletion of GSTM1 and GSTT1 genes (both null deletion) with HIV/AIDS disease progression in Ghanaian patients. 29795558 2018
CUI: C0014518
Disease: Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis
0.010 GeneticVariation disease BEFREE The GSTM1 null genotype was more frequent in the cases with SJS/TEN than in the controls (OR = 2.94, P = 0.027). 28689274 2017